Now showing items 1-3 of 3
Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study
(Elsevier Inc., 2019-05-02)
Introduction: We sought to determine if our previously validated proteomic profile for detecting Alzheimer's disease would detect Parkinson's disease (PD) and distinguish PD from other neurodegenerative diseases. Methods: ...
A proteomic signature for dementia with Lewy bodies
(Elsevier Inc., 2019-03-15)
Introduction: We sought to determine if a proteomic profile approach developed to detect Alzheimer's disease would distinguish patients with Lewy body disease from normal controls, and if it would distinguish dementia with ...
Identification of long non-coding RNA-related and -coexpressed mRNA biomarkers for hepatocellular carcinoma
(BioMed Central Ltd., 2019-01-31)
Background: While changes in mRNA expression during tumorigenesis have been used widely as molecular biomarkers for the diagnosis of a number of cancers, the approach has limitations. For example, traditional methods do ...